Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/22/20241:45AMBusiness WireMADES, a Latecoere Company, recognized by RTX with a Premier Award for performance in 2023TSXV:LATLatin American Minerals Inc
05/22/20241:45AMBusiness WireMADES, une entreprise du groupe Latecoere, reconnue par RTX avec un « Premier Award » pour ses performances en 2023TSXV:LATLatin American Minerals Inc
05/22/20241:40AMPR Newswire (US)COMPUTEX 2024 Preview | Embracing the Era of High-Capacity SSDs
05/22/20241:38AMGlobeNewswire Inc.Novaturas Group earned EUR 34.5 mln. in the first quarter
05/22/20241:33AMAlliance NewsAlliance NewsGET READY: British Land, Close Brothers, M&S, RS, SSE at 0700 BST
05/22/20241:31AMAlliance NewsAlliance NewsAlliance News UK - start of day
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentLSE:AALBAalberts
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesLSE:0RADOse Immunotherapeutics Sa
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesTG:6OPOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesEU:OSEOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesLSE:0RADOse Immunotherapeutics Sa
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentTG:AACAAalberts NV
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesTG:6OPOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
05/22/20241:30AMGlobeNewswire Inc.Nextensa offers its shareholders an optional dividendEU:NEXTANextensa SA
05/22/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
05/22/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
05/22/20241:30AMGlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelLSE:0NUTNextensa
05/22/20241:30AMGlobeNewswire Inc.Nextensa offers its shareholders an optional dividendLSE:0NUTNextensa
05/22/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
05/22/20241:30AMGlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelEU:NEXTANextensa SA
05/22/20241:30AMGlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
05/22/20241:25AMGlobeNewswire Inc.Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, BelgiumNYSE:BHPBHP Group Limited
05/22/20241:16AMBusiness WireHAFNIA LIMITED: Ex-Dividend USD 0.3443 TodayNYSE:HAFNHafnia Ltd
05/22/20241:06AMAlliance NewsAlliance NewsJapan's trade deficit widens in April, as export growth falls short
05/22/20241:05AMBusiness WireKey Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)NYSE:CLCOCool Company LTD

Your Recent History